BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25102962)

  • 21. Tuberculosis and granuloma formation in patients receiving anti-TNF therapy.
    Iliopoulos A; Psathakis K; Aslanidis S; Skagias L; Sfikakis PP
    Int J Tuberc Lung Dis; 2006 May; 10(5):588-90. PubMed ID: 16704045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors and Outcomes of Nontuberculous Mycobacterial Disease among Rheumatoid Arthritis Patients: A Case-Control study in a TB Endemic Area.
    Liao TL; Lin CF; Chen YM; Liu HJ; Chen DY
    Sci Rep; 2016 Jul; 6():29443. PubMed ID: 27404002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.
    Sichletidis L; Settas L; Spyratos D; Chloros D; Patakas D
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1127-32. PubMed ID: 17044206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and clinical characteristic of mycobacterial infections in human immunodeficiency virus-infected patients in Siriraj Hospital.
    Chayakulkeeree M; Naksanguan T
    J Med Assoc Thai; 2015 Mar; 98(3):238-44. PubMed ID: 25920293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
    Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
    J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-α Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence.
    Kisacik B; Pamuk ON; Onat AM; Erer SB; Hatemi G; Ozguler Y; Pehlivan Y; Kilic L; Ertenli I; Can M; Direskeneli H; Keser G; Oksel F; Dalkilic E; Yilmaz S; Pay S; Balkarli A; Cobankara V; Cetin GY; Sayarlioglu M; Cefle A; Yazici A; Avci AB; Terzioglu E; Ozbek S; Akar S; Gul A
    J Rheumatol; 2016 Mar; 43(3):524-9. PubMed ID: 26773107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study.
    Corbett EL; Churchyard GJ; Clayton T; Herselman P; Williams B; Hayes R; Mulder D; De Cock KM
    Am J Respir Crit Care Med; 1999 Jan; 159(1):94-9. PubMed ID: 9872824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials.
    Aksamit TR; Philley JV; Griffith DE
    Respir Med; 2014 Mar; 108(3):417-25. PubMed ID: 24484653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study.
    Bermejo F; Algaba A; Chaparro M; Taxonera C; Garrido E; García-Arata I; Guerra I; Gisbert JP; Olivares D; de-la-Poza G; López-Sanromán A
    Dig Liver Dis; 2013 Sep; 45(9):733-7. PubMed ID: 23587496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risks for opportunistic tuberculosis infection in a cohort of 873 patients with inflammatory bowel disease receiving a tumor necrosis factor-α inhibitor.
    Byun JM; Lee CK; Rhee SY; Kim HJ; Im JP; Park DI; Eun CS; Jung SA; Shin JE; Lee KM; Cheon JH
    Scand J Gastroenterol; 2015 Mar; 50(3):312-20. PubMed ID: 25581784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.
    Knoll BM; Kappagoda S; Gill RR; Goldberg HJ; Boyle K; Baden LR; Fuhlbrigge AL; Marty FM
    Transpl Infect Dis; 2012 Oct; 14(5):452-60. PubMed ID: 22676720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterial disease in patients with rheumatic disease.
    van Ingen J; Boeree MJ; Dekhuijzen PN; van Soolingen D
    Nat Clin Pract Rheumatol; 2008 Dec; 4(12):649-56. PubMed ID: 19037226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area.
    Park DW; Kim YJ; Sung YK; Chung SJ; Yeo Y; Park TS; Lee H; Moon JY; Kim SH; Kim TH; Yoon HJ; Sohn JW
    Sci Rep; 2022 Mar; 12(1):4003. PubMed ID: 35256729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis.
    Inanc N; Aydin SZ; Karakurt S; Atagunduz P; Yavuz S; Direskeneli H
    J Rheumatol; 2009 Dec; 36(12):2675-81. PubMed ID: 19918035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review.
    Mori S; Sugimoto M
    Clin Rheumatol; 2012 Feb; 31(2):203-10. PubMed ID: 22170032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis.
    Cavazzana I; Taraborelli M; Fredi M; Tincani A; Franceschini F
    Clin Exp Rheumatol; 2014; 32(5):732-4. PubMed ID: 25198168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pulmonary tuberculosis associated to adalimumab: a study of 3 cases].
    Blanco Pérez JJ; Aranda Torres A; Pego Reigosa JM; Núñez Delgado M; Temes Montes E; Guerra Vales JL
    Arch Bronconeumol; 2010 Apr; 46(4):203-5. PubMed ID: 19896259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area.
    Kim HW; Park JK; Yang JA; Yoon YI; Lee EY; Song YW; Kim HR; Lee EB
    Clin Rheumatol; 2014 Sep; 33(9):1307-12. PubMed ID: 24057090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of tuberculosis in rheumatoid arthritis patients on tumour necrosis factor-alpha inhibitor treatment in Taiwan.
    Ke WM; Chen LS; Parng IM; Chen WW; On AW
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1590-5. PubMed ID: 24200274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.